Kaplan-meier analysis of a patient-based local control, b lesion-based local control, c out of field central nervous system (CNS) progression, d extra-CNS (eCNS) progression, e progression-free survival, and f overall survival, for patients receiving immune checkpoint inhibitors within 8 weeks of stereotactic radiosurgery